Getting latest data loading
Home / Blog / Accendo Markets

US Producer Prices & Retail Sales figures – Better

CFDs & Spread  Betting with Accendo Markets

ASTRAZENECA (AZN) UPS GUIDANCE (14th Aug 2012)

Mike van Dulken, Head of Research at Accendo Markets, commented: AstraZeneca (AZN) shares are today registering their first bounce in 7 days as investors react to the positive news that the pharmaceutical giant has increased FY 2012 earnings guidance from $6.00 to $6.30 per share. This comes on the back of the group announcing a…

Raft of European Data; EZ GDP in-line, German ZEW surveys mixed

CFDs & Spread Betting with Accendo Markets

UK inflation higher than expected

CFDs & Spread Betting with Accendo Markets

Greek Q2 prelim GDP not as weak as expected

CFDs & Spread Betting with Accendo Markets

US Import/Export Prices better; Canadian Employment worse

Spread Betting with Accendo Markets

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.